CN110894551A - RAA constant-temperature fluorescence detection method and reagent for grass carp hemorrhagic disease type I virus (GCRV-I) - Google Patents
RAA constant-temperature fluorescence detection method and reagent for grass carp hemorrhagic disease type I virus (GCRV-I) Download PDFInfo
- Publication number
- CN110894551A CN110894551A CN201811069533.XA CN201811069533A CN110894551A CN 110894551 A CN110894551 A CN 110894551A CN 201811069533 A CN201811069533 A CN 201811069533A CN 110894551 A CN110894551 A CN 110894551A
- Authority
- CN
- China
- Prior art keywords
- virus
- grass carp
- disease type
- raa
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000700605 Viruses Species 0.000 title claims abstract description 59
- 241000252230 Ctenopharyngodon idella Species 0.000 title claims abstract description 55
- 238000000034 method Methods 0.000 title claims abstract description 25
- 238000001917 fluorescence detection Methods 0.000 title claims abstract description 9
- 208000031169 hemorrhagic disease Diseases 0.000 title claims description 31
- 239000003153 chemical reaction reagent Substances 0.000 title claims description 17
- 238000001514 detection method Methods 0.000 claims abstract description 43
- 208000032843 Hemorrhage Diseases 0.000 claims abstract description 22
- 239000007850 fluorescent dye Substances 0.000 claims abstract description 21
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 19
- 102100034343 Integrase Human genes 0.000 claims abstract description 6
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 claims abstract description 6
- 239000000523 sample Substances 0.000 claims description 29
- 230000003321 amplification Effects 0.000 claims description 24
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 24
- 108020004707 nucleic acids Proteins 0.000 claims description 16
- 102000039446 nucleic acids Human genes 0.000 claims description 16
- 150000007523 nucleic acids Chemical class 0.000 claims description 16
- 208000034158 bleeding Diseases 0.000 claims description 15
- 230000000740 bleeding effect Effects 0.000 claims description 15
- 239000002773 nucleotide Substances 0.000 claims description 12
- 125000003729 nucleotide group Chemical group 0.000 claims description 12
- 239000013612 plasmid Substances 0.000 claims description 11
- 239000000843 powder Substances 0.000 claims description 10
- 108090000623 proteins and genes Proteins 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 238000010791 quenching Methods 0.000 claims description 7
- 230000000171 quenching effect Effects 0.000 claims description 7
- 125000006853 reporter group Chemical group 0.000 claims description 7
- SEQKRHFRPICQDD-UHFFFAOYSA-N N-tris(hydroxymethyl)methylglycine Chemical compound OCC(CO)(CO)[NH2+]CC([O-])=O SEQKRHFRPICQDD-UHFFFAOYSA-N 0.000 claims description 6
- 239000000872 buffer Substances 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 5
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 4
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 4
- 102000004420 Creatine Kinase Human genes 0.000 claims description 3
- 108010042126 Creatine kinase Proteins 0.000 claims description 3
- 108060002716 Exonuclease Proteins 0.000 claims description 3
- VHJLVAABSRFDPM-IMJSIDKUSA-N L-1,4-dithiothreitol Chemical compound SC[C@H](O)[C@@H](O)CS VHJLVAABSRFDPM-IMJSIDKUSA-N 0.000 claims description 3
- 238000010802 RNA extraction kit Methods 0.000 claims description 3
- 101710176276 SSB protein Proteins 0.000 claims description 3
- 101710126859 Single-stranded DNA-binding protein Proteins 0.000 claims description 3
- UZMAPBJVXOGOFT-UHFFFAOYSA-N Syringetin Natural products COC1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UZMAPBJVXOGOFT-UHFFFAOYSA-N 0.000 claims description 3
- 239000007997 Tricine buffer Substances 0.000 claims description 3
- KCFYHBSOLOXZIF-UHFFFAOYSA-N dihydrochrysin Natural products COC1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 KCFYHBSOLOXZIF-UHFFFAOYSA-N 0.000 claims description 3
- 102000013165 exonuclease Human genes 0.000 claims description 3
- 101150079601 recA gene Proteins 0.000 claims description 3
- UDGUGZTYGWUUSG-UHFFFAOYSA-N 4-[4-[[2,5-dimethoxy-4-[(4-nitrophenyl)diazenyl]phenyl]diazenyl]-n-methylanilino]butanoic acid Chemical compound COC=1C=C(N=NC=2C=CC(=CC=2)N(C)CCCC(O)=O)C(OC)=CC=1N=NC1=CC=C([N+]([O-])=O)C=C1 UDGUGZTYGWUUSG-UHFFFAOYSA-N 0.000 claims description 2
- 101100300807 Drosophila melanogaster spn-A gene Proteins 0.000 claims description 2
- 238000002123 RNA extraction Methods 0.000 claims description 2
- 238000010839 reverse transcription Methods 0.000 claims description 2
- 239000003161 ribonuclease inhibitor Substances 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 claims description 2
- FFYPMLJYZAEMQB-UHFFFAOYSA-N diethyl pyrocarbonate Chemical compound CCOC(=O)OC(=O)OCC FFYPMLJYZAEMQB-UHFFFAOYSA-N 0.000 claims 2
- 239000003419 rna directed dna polymerase inhibitor Substances 0.000 claims 1
- 230000035945 sensitivity Effects 0.000 abstract description 9
- 239000012295 chemical reaction liquid Substances 0.000 abstract 1
- 239000013558 reference substance Substances 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 description 10
- 238000012360 testing method Methods 0.000 description 7
- 241000546112 Infectious salmon anemia virus Species 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 238000003757 reverse transcription PCR Methods 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 3
- 241000609060 Grass carp reovirus Species 0.000 description 3
- 241000710921 Infectious pancreatic necrosis virus Species 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 235000019688 fish Nutrition 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 101710082933 Single-strand DNA-binding protein Proteins 0.000 description 2
- 238000009360 aquaculture Methods 0.000 description 2
- 244000144974 aquaculture Species 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- FLKPEMZONWLCSK-UHFFFAOYSA-N diethyl phthalate Chemical compound CCOC(=O)C1=CC=CC=C1C(=O)OCC FLKPEMZONWLCSK-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- 208000009663 Acute Necrotizing Pancreatitis Diseases 0.000 description 1
- 241000710929 Alphavirus Species 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000252233 Cyprinus carpio Species 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010058096 Pancreatic necrosis Diseases 0.000 description 1
- 102000018120 Recombinases Human genes 0.000 description 1
- 108010091086 Recombinases Proteins 0.000 description 1
- 241000702247 Reoviridae Species 0.000 description 1
- 241000702263 Reovirus sp. Species 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 201000005008 bacterial sepsis Diseases 0.000 description 1
- 210000000234 capsid Anatomy 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000012864 cross contamination Methods 0.000 description 1
- 230000000120 cytopathologic effect Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000011841 epidemiological investigation Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001506 fluorescence spectroscopy Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 238000003205 genotyping method Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 238000011901 isothermal amplification Methods 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000004451 qualitative analysis Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 241001529453 unidentified herpesvirus Species 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
Abstract
The invention discloses a grass carp hemorrhage disease type I virus (GCRV-I) RAA constant-temperature fluorescence detection method and a detection kit. The detection kit comprises a forward primer SEQ ID NO.1, a reverse primer SEQ ID NO.2, a specific fluorescent probe SEQ ID NO.3, reaction liquid, reverse transcriptase, recombinant polymerase and a reference substance. The kit has strong specificity; the detection sensitivity is high and can reach 1.89 fg/mu L; the accuracy is high and reliable; the method is simple, convenient and quick to operate, is suitable for field detection, and has wide application scenes.
Description
Technical Field
The invention belongs to the technical field of molecular biology, relates to a detection method of marine aquaculture industry, and particularly relates to an RAA constant-temperature fluorescence detection method and a kit for grass carp hemorrhagic disease type I virus.
Background
Grass carp hemorrhagic disease virus (GCRV) belongs to the aquatic reovirus genus, is a new member of the reoviridae family, and is the first fish virus isolated from the mainland of China. The virus mainly causes the grass carp species in fresh water culture in Asian countries such as China, Vietnam, Myanmar and the like to generate leukemia at the fingerling stage, and the death rate can reach more than 60 percent. The virus has wide prevalence, great harm, high mortality, long morbidity season and serious threat to fishery production. The grass carp reovirus has a double-layer capsid, the average diameter of virus particles is 60 nm-70 nm, the icosahedron is symmetrical, and has no envelope, and the genome consists of 11 segmented double-stranded RNAs. More than 20 isolates have been reported at present, including GCRV854, GCRV861, GCRV873, GCRV875, GCRV876, GCRV991, GCRV H962, ZV-8802, GCRV-854, GCRVHZ08, GCRV JX09-01, GCRV JX09-02, GCRVGD10, GCRV GCRV104 and the like, and different isolates have large differences in genome sequence, genome banding, cytopathic effect, pathogenicity to grass carp and the like. The strains which have been subjected to whole genome sequence analysis so far include strain GCRV873, GCRVHZ08, GCRV GD10, GCRV104 and the like, and more strains only complete sequencing work of partial segments or partial sequences. The grass carp reovirus is relatively complex, and the reassortment and antigen drift phenomena exist in each gene segment of different isolates, so that the subtype classification of the grass carp reovirus on serology or genotype is not carried out at present. However, there should be at least three types of isolates from the existing isolate sequence information, and the representative strains of each type are: the first type is 873 strains and JX09-01 strains, the second type is HZ08 strains and GD10 strains, and the third type is 104 strains. In the related research reports, the research on genotyping is mentioned, namely, the first, second and third types are classified into I, II and III according to the difference of gene sequences.
Currently, three subtypes of epidemic strains separated from all over the country are reported, and some subtypes are infected singly and also are infected mixedly. According to the grass carp hemorrhage monitoring and epidemiological investigation and analysis in recent years, the grass carp hemorrhage epidemics and outbreaks are mainly GCRV type II and are secondarily GCRV type I at present.
The detection method for grass carp bleeding type I virus is various, and virus separation, electron microscope observation and nucleic acid banding type analysis are still the commonly adopted methods for detecting grass carp bleeding type I virus, but the existing methods have certain defects, such as: the histopathology-based method is not only tedious and time-consuming to operate, but also low in sensitivity; although the method based on immunology has the characteristics of high sensitivity, quick detection and the like, and can be used for detecting a large number of samples, the false positive problem generated when a fresh sample is detected also limits the wide application of the method to a certain extent; the PCR method is sensitive, accurate and rapid, can replace the etiology detection, but is not suitable for the field rapid detection and the basic popularization and application due to the need of expensive instruments and equipment, higher detection cost and higher technical requirements on detection personnel. Compared with the common PCR technology, the fluorescent PCR detection technology simplifies the operation steps, can eliminate the cross contamination caused by the amplification product and reduce the occurrence of false positive. However, the real-time fluorescent PCR is long in time consumption and high in cost, and is not applied to conventional pathogen detection of aquaculture animals at present. The LAMP isothermal amplification technology is also relatively limited in application in aquatic pathogen detection due to higher false positive and low accuracy. The invention establishes a method for detecting grass carp bleeding disease type I virus by RAA constant temperature fluorescence, is quick, convenient, accurate and reliable, is suitable for port quick detection and the time requirement of the major customs, and has important effect on promoting the marine culture of China and the trade of products thereof.
The Recombinase-aid Amplification (RAA) technique is also a method by which nucleic acids can be rapidly amplified at a constant temperature. Unlike RPA, RAA amplification uses a recombinase obtained from bacteria or fungi, which binds tightly to the primer DNA at a constant temperature of 37 ℃ to form an aggregate of the enzyme and the primer, when the primer searches for a sequence on the template DNA that is completely complementary to the primer, the template DNA is melted with the help of single-strand DNA binding protein (SSB), and a new complementary strand of DNA is formed under the action of DNA polymerase, and the reaction product is exponentially increased, and usually an amplified fragment that can be detected by agarose gel electrophoresis can be obtained within 1 hour. The fluorescent group is added into the RAA reaction system, the whole RAA amplification process is monitored in real time by utilizing the accumulation of fluorescent signals, and the quantitative and qualitative analysis of the initial template can be realized within 20 minutes. The whole reaction is simple and quick, and high-temperature circulation is not needed, so the method is particularly suitable for being used in non-laboratory detection places with a large number of samples, and is suitable for the field of quick detection of foods.
Disclosure of Invention
In view of the above, the present invention provides a RAA constant temperature fluorescent nucleic acid detection kit and a detection method for grass carp hemorrhagic disease type I virus (GCRV-I).
In order to achieve the purpose, the invention adopts the following technical scheme:
a detection kit for grass carp hemorrhagic disease type I virus (GCRV-I) nucleic acid comprises: the kit comprises a grass carp bleeding disease type I virus forward primer, a reverse primer and a specific fluorescent probe, wherein the nucleotide sequence of the grass carp bleeding disease type I virus forward primer is shown as SEQ ID No.1, the nucleotide sequence of the grass carp bleeding disease type I virus reverse primer is shown as SEQ ID No.2, the nucleotide sequence of the specific fluorescent probe is shown as SEQ ID No.3, a fluorescent reporter group is marked at the 5 'end of the specific fluorescent probe, and a fluorescent quenching group is marked at the 3' end of the specific fluorescent probe.
In some embodiments, the fluorescent reporter group of the specific fluorescent probe is selected from one of FAM, VIC, JOE, TET, CY3, CY5, ROX, Texas Red, or LC Red460, and the fluorescence quenching gene is selected from one of BHQ1, BHQ2, BHQ3, Dabcy1, or Tamra.
In some embodiments, the nucleic acid detection kit further comprises at least one of a primer mixture, a specific fluorescent probe, an a Buffer, a B Buffer, a RAA dry powder reagent, a grass carp hemorrhagic disease type I virus standard, and DEPC treated water.
In some embodiments, the kit, the reverse transcription system consists of a RTE reverse transcriptase, an rnase inhibitor.
In some embodiments, the kit of (a), wherein the a Buffer is 20% PEG; b Buffer is 280mM MgAc.
In some embodiments, the kit, wherein the composition of the RAA dry powder reagent is as follows: 1mmol/L dNTP, 90ng/μ L SSB protein, 120ng/μ L recA recombinase protein (SC-recA/BS-recA) or 30ng/μ LRad51, 30ng/μ L Bsu DNA polymerase, 30ng/mL RTE reverse transcriptase, 100mmol/L Tricine, 20% PEG, 5mmol/L dithiothreitol, 100ng/μ L creatine kinase, Exo exonuclease.
In some embodiments, the nucleic acid detection kit and the grass carp bleeding disease type I virus standard are positive plasmids containing partial sequences of grass carp bleeding disease type I virus conserved genes.
In some embodiments, the kit comprises a positive plasmid containing a partial sequence of a grass carp hemorrhagic disease type I virus conserved region gene as shown in SEQ ID No. 4.
The invention also provides an RAA constant temperature fluorescence detection method of the grass carp bleeding disease type I virus, which comprises the steps of extracting RNA of a sample to be detected, carrying out real-time fluorescence RAA reaction in the presence of a forward primer, a reverse primer, a specific fluorescence probe, an RAA dry powder reagent, A Buffer, B Buffer and DEPC (diethyl phthalate) treated water of the grass carp bleeding disease type I virus by taking the RNA of the sample to be detected as a template, and analyzing the sample to be detected according to a real-time fluorescence RAA amplification curve; the nucleotide sequence of the grass carp hemorrhagic disease type I virus forward primer is shown as SEQ ID No.1, the nucleotide sequence of the grass carp hemorrhagic disease type I virus reverse primer is shown as SEQ ID No.2, the nucleotide sequence of the specific fluorescent probe is shown as SEQ ID No.3, the 5 'end of the specific fluorescent probe is marked with a fluorescent reporter group, and the 3' end of the specific fluorescent probe is marked with a fluorescent quenching group.
In some embodiments, the RNA extraction of the grass carp hemorrhagic disease type I virus nucleic acid is performed by using a traditional Trizol-RNA reagent or an equivalent RNA extraction kit.
In some embodiments, the performing a fluorescent RAA reaction procedure is: at 39 ℃ for 40 s; at 39 ℃ for 20min, and 40 cycles in total;
according to the detection method, after the real-time fluorescence RAA reaction is required to be finished, the to-be-detected sample is analyzed according to the amplification curve of the real-time fluorescence RAA by using the analysis software of the real-time fluorescence RAA instrument. Preferably, the FAM channel fluorescence curve of the sample to be tested is S-shaped, the CT value is less than or equal to 35, and the sample to be tested is judged to be a positive result of the grass carp hemorrhagic disease type I virus; and when the curve of the sample to be detected is not S-shaped or the CT value is more than 35, judging that the grass carp has a negative result of the hemorrhagic disease type I virus.
Advantageous effects
1. Fast and efficient: the whole amplification can be completed within 20-30min, and the amplification yield can reach 109-1010A copy;
2. the operation is simple: no special reagent is needed, complicated steps such as deformation of double-stranded DNA and the like are not needed in advance, only a constant-temperature fluorometer is needed, and the conditions are mild;
3. high specificity: other conditions of the invention are found in fish such as eel Herpes Virus (HVA), infectious pancreatic necrosis disease (IPNV), carp edema disease (CEV), bacterial sepsis (FBS), Salmon Alphavirus (SAV) and Infectious Salmon Anaemia Virus (ISAV).
4. High sensitivity: the detection limit of the invention can reach 1.89 fg/microliter reaction.
5. The identification is simple: and the amplification result is directly judged according to the real-time fluorescence data, electrophoresis detection is not needed, and the method is suitable for field detection.
Drawings
FIG. 1 is a graph showing the amplification of 4 pairs of primers RAA involved in the present invention.
FIG. 2 is a graph showing the sensitivity test of the RAA detection method to GCRV-I, and the amplification results of the positive standard samples are 1893 fg/. mu.L, 189.3 fg/. mu.L, 18.93 fg/. mu.L, 1.89 fg/. mu.L and 0.19 fg/. mu.L from left to right.
FIG. 3 is a diagram showing the experiment of specificity of RAA detection method for GCRV-I.
Detailed description of the invention
The present invention is further illustrated by the following specific examples, but is not limited thereto.
Example 1:
the invention searches gene sequences of grass carp hemorrhagic disease type I virus strains in a Genebank database for grass carp hemorrhagic disease type I virus, and compares multiple sequences by using DNAMAN6.0 software to find out conserved segments. 4 sets of primers and probes were designed in the conserved regions and BLAST alignments were performed in the NCBI database, with the sequences of the primers and probes as shown in Table 1. The positive sample amplification curve is shown in FIG. 1.
Table 1 primer and probe sequences:
as can be seen from the results in FIG. 1, the amplification curves for the fourth set of primers and probes are most typical, with distinct exponential and plateau phases, with higher fluorescence intensity (ordinate values), and with smaller CT values (crossing of the curve with the threshold line)
The corresponding abscissa) the analysis of the results is shown in table 2. The rise height of other primer probe curves is lower, the CT value is larger, and the plateau period is not obvious; or no amplification occurs and missed detection occurs. The fourth group of primers and the target products of the probes have higher replication speed, more quantity and higher amplification reaction efficiency.
TABLE 2 analysis of primer Probe screening results
| Group \ result | CT value | Intensity of fluorescence |
| First group | 12.87 | 250,000 |
| Second group | 7.35 | 270,000 |
| Third group | 9.69 | 330,000 |
| Fourth group | 7.35 | 390,000 |
Real-time example 2: the kit is used for treating grass carp hemorrhagic disease type I virus
The nucleic acid detection kit also comprises a primer mixed solution, a specific fluorescent probe, an A Buffer, a BBbuffer, an RAA dry powder reagent, a grass carp hemorrhage disease type I virus standard substance and DEPC treated water.
The kit of the invention, wherein the A Buffer is 20% PEG; b Buffer is 280mM MgAc.
The kit of the invention, wherein the RAA dry powder reagent comprises the following components: 1mmol/L dNTP, 90ng/μ L SSB protein, 120ng/μ L recA recombinase protein (SC-recA/BS-recA) or 30ng/μ L Rad51, 30ng/μ L Bsu DNA polymerase, 100mmol/L Tricine, 20% PEG, 5mmol/L dithiothreitol, 100ng/μ L creatine kinase, Exo exonuclease, 30ng/mL RTE reverse transcriptase.
In the primer mixture, the base sequence of the forward primer is shown as SEQ ID NO.1, the base sequence of the reverse primer is shown as SEQ ID NO.2, and the molar ratio of the forward primer to the reverse primer is SEQ ID NO. 1: SEQ ID NO.2 is 1: 1.
The base sequence of the specific probe for the grass carp hemorrhagic disease type I virus is shown in SEQ ID NO.3, the 5 'end of the probe is marked with an FAM fluorescent reporter group, and the 3' end of the probe is marked with a BHQ1 fluorescent quenching group.
The grass carp hemorrhage disease type I virus standard provided by the invention comprises a positive plasmid of a grass carp hemorrhage disease type I virus conserved region gene sequence, and the base sequence of the plasmid is shown as SEQ ID NO. 4.
Base sequence of plasmid (SEQ ID NO.4):
GTTATTTCGACACTTCGCACTCTCTCTACAATGGGGAACGTTCAAACCTCCGTCAACACTTACAATATTACTGGGGATGGTAATTCATTTACCCCCACCTCTGACATGACATCCACCGCCGCCCCGGCCATTGACCTCAAACCTGGGGTTCTCAATCCTACCGGTAAGCTATGGCGACCCGTCGGTACCTCTGTTGCTACCATCGACTCACTTGCCATCGTTAGCGATCGTTTTGGTCAGTATTCATTTGTCAATGAAGGCATGCGAGAGACCTTTTCAAAAGCGCTCTTCGACATCAACATGTGGCAACCTTTATTCCAAGCGACAAAGACTGGCTGCGGACCGATTGTACTCTCCTCCTTCACAACCACCACCTCCGGTTATGTTGGCGCCACCGCCGGTGATGCCCTTGACAACCCTGTAACGAATGGCGTTTTCATCAGTACTGTGCAAATCATGAACCTTCAGCGGACCATCGCTGCCCGCATGCGTGACGTCGCTCTCTGGCAGAAACACTTAGACACCGCCATGACCATGCTAACACCTGACATTTCTGCCGGTAGCGCCTCCTGCAACTGGAAGAGCTTGCTCGCTTTTGCGAAGGATATCCTCCCCCTCGACAACCTGTGCCTCACCTACCCAAATGAGTTCTACAACGTTGCCATCCACCGCTATCCCGCACTCAAGCCTGGTAACCCAGACACCAAGCTTCCCGATGCCCAGGCTCATCCGCTGGGAGAAGTAGCCGGTGCGTTCAATGCCGCCACCTCTGAAGTTGGGAGTCTCGTTGGTTCCAGCTCCACCCTCTCACAGGCCATCTCCACCATGGCTGGCAAAGACCTCGATCTAATTGAAGCCGACACTCCGCTCCCCGTGAGCGTATTTACTCCATCTCTCGCCCCTCGTTCTTATCGACCCGCCTTCATTAAACCTGAGGATGCTAAGTGGATCGCGGAATTCAATAACTCATCCCTCATACGTAAGACTCTTACCTACTCGGGTGCCACCTACACCGTTCAACTCGGCCCTGGTCCAACTCGCGTCATTGATATGAATGCGATGATCGACTCCGTGTTGACCCTGGATGTGAGCGGTACCATCCTCCCATATGACACAAACCCTGATCTGTCTACTTCAGTCCCGGCTTTCGTCCTCATCCAGACCTCAGTACCAATTCAACAAGTCACTACCGCTGCTAACATCACAGCCATCACCGTCGTATCCGCCGCTGGCGCTTCCGCCATCAATCTCGCTATCAATGTACGCGGCCAGCCCCGCTTCAACATGCTCCACCTGCAAGCCACCTTTGAGCGCGAGACAATCACCGGGATCCCGTATATCTATGGCTTGGGCACATTCCTCATCCCATCACCCACATCCTCCTCCAATTTCTCCAACCCCACGCTGATGGACGGCCTTCTCACTGTCACCCCCGTACTGCTACGTGAGACGACATACAAGGGCGAAGTCGTTGACGCTATCGTACCAGCTACCGTCATGGCCAACCAAACGTCTGAGGAGGTCGCCTCTGCCTTAGCCAACGACGCGATCGTGTTAGTGTCGAATCATCTCAACAAGTTGGCCAATGTCGTAGGAGACGCGATTCCCGTCGCCTCAAGAACGGATGATTCCGCGACTAGCGCCATCGTCAGTCGACTCGCCGTCCAGCACAAGCTGTCACAGGTAGGCCAAGCCTCACCCACTCCCCCCGATTATCCACTTCTGTGGCGCCGTGCCAAGCGTGCCGCGTCTATGTTCGTCTCCAACCCCTCCCTGGCCTTGCAGGTAGGTATCCCTGTGTTAACTCAATCTGGTATGCTTTCCGCCCTAACGTCTGGCGTAGGCACGGCTTTACGTACTGGTAGCTTGGGCAAAGGTGTAACCGATGCGTCAGAAAAACTACGTGCACGTCAGAGTTTGACGGTTGCGAAGCAAGCGTTCTTCGACCAGATAGGGAGCTTGTGGCCCGGCAAGTGAGGGGTGGGTTGACAACCCCCTTCCATGCCCGCGTGAACGGCGGGAAGTGTCGTACTTTCATC
the DEPC treated water provided by the invention is purchased from Solambio company.
Example 3: the kit of the invention is used for grass carp hemorrhagic disease type I virus
1. Extraction of nucleic acids from Positive samples
1.1, nucleic acid extraction: conventional Trizol-RNA reagents or an equivalent RNA extraction kit were used.
2. Configuration of RAA reaction system: one RAA reaction dry powder tube was used for each test sample, and the reaction components and the added volume in each RAA reaction dry powder tube are shown in Table 3.
Table 3:
| RAA reaction system component | Volume (μ L) |
| A Buffer | 12.5μL |
| B Buffer | 2.5μL |
| Primer mixture | 4μL |
| Specific fluorescent probe | 0.6μL |
| DNA template | 2μL |
| DEPC treated Water | 28.4μL |
| Total volume | 50μL |
A Buffer is 20% PEG; b Buffer is 280mM MgAc
3. Placing the RAA reaction tube with the prepared reaction system in an ABI7500 amplification instrument, and carrying out RAA amplification according to the following procedures: at 37 ℃ for 40 s; at 37 ℃ for 20min, for a total of 40 cycles. Fluorescence of FAM channels was collected for each cycle.
4. And after the amplification is finished, judging the positive or negative result of the grass carp hemorrhagic disease type I virus according to the fluorescence curve judgment and the CT value.
And (4) judging the result: the fluorescence curve of the FAM channel is S-shaped, the CT value is less than or equal to 35, and the positive result is judged to be the grass carp hemorrhagic disease type I virus; and when the curve of the sample to be detected is not S-shaped or the CT value is more than 35, judging that the grass carp has a negative result of the hemorrhagic disease type I virus.
Example 4: evaluation of RAA detection kit of the invention in clinical practical application
The kit is adopted to carry out clinical blind sample experiments, and 48 parts of fishes are detected; experimental results show that the fourth primer pair can distinguish grass carp hemorrhagic disease type I virus, and has high positive coincidence rate with reverse transcription PCR. In 50 parts, 26 parts of the reverse transcription PCR are positive results, 22 parts of the reverse transcription PCR are negative results, 27 parts of the results detected by the RAA method are positive, 21 parts of the results are negative results, and one part of the positive results are different, the sample is subjected to reverse transcription PCR amplification and sequencing, and the sequencing result shows that the sample is positive, so that the RAA detection reagent has higher accuracy.
Test example 5: sensitivity test of the kit of the invention
The grass carp hemorrhage type I virus standard plasmid provided by the kit in the embodiment 2 of the invention is extracted to obtain positive plasmids, the concentration of the positive plasmids is measured by using NanoDrop, and the positive plasmids are respectively diluted to 1893 fg/muL, 189.3 fg/muL, 18.93 fg/muL, 1.89 fg/muL and 0.19 fg/muL to carry out sensitivity tests by 5 concentration gradients.
As shown in FIG. 2, the detection results are 1893fg/μ L, 189.3fg/μ L, 18.93fg/μ L, 1.89fg/μ L and 0.19fg/μ L positive standard amplification results from left to right, from which it can be seen that the RAA fluorescence amplification reagent and the detection sensitivity of the invention can reach 1.89fg/μ L, the accuracy is better than that of the ordinary PCR detection method, which indicates that the RAA constant temperature fluorescence detection kit and the detection method of the invention have high sensitivity for GCRV-I diagnosis.
Test example 6: specificity test of the kit of the present invention
In order to detect the specificity of the kit, the detection methods in example 3 are adopted to respectively detect the HVA, IPNV, CEV, SAV, ISAV and FBS samples of viruses, and the detection conditions of the kit on GCRV-I and other common viruses of prawns are analyzed.
The detection result shows that: normal amplification occurred with GCRV-I samples only, and no amplification occurred with negative controls (DEPC-treated water) and with none of the HVA, IPNV, CEV, SAV, ISAV and FBS samples (as shown in FIG. 3). The results show that the RAA constant temperature fluorescence detection kit can specifically amplify the target sequence in GCRV-I without cross reaction with other virus nucleic acids. The method and the kit have good specificity and do not generate false negative.
Meanwhile, the same specificity experiment is carried out on the primers 1-3 designed by the invention, and the primers can not distinguish different samples well and have poor specificity (the specific experimental data is slight).
The invention shown and described herein may be practiced in the absence of any element or elements, limitation or limitations, which is specifically disclosed herein. The terms and expressions which have been employed are used as terms of description and not of limitation, and there is no intention in the use of such terms and expressions of excluding any equivalents of the features shown and described or portions thereof, and it is recognized that various modifications are possible within the scope of the invention. It should therefore be understood that although the present invention has been specifically disclosed by various embodiments and optional features, modification and variation of the concepts herein described may be resorted to by those skilled in the art, and that such modifications and variations are considered to be within the scope of this invention as defined by the appended claims.
The contents of the articles, patents, patent applications, and all other documents and electronically available information described or cited herein are hereby incorporated by reference in their entirety to the same extent as if each individual publication was specifically and individually indicated to be incorporated by reference. Applicants reserve the right to incorporate into this application any and all materials and information from any such articles, patents, patent applications, or other documents.
Sequence listing
<110> Hangzhou Zhongzhuang Biotech Co., Ltd
<120> RAA constant temperature fluorescence detection method and reagent for grass carp hemorrhagic disease type I virus (GCRV-I)
<130>18-100070-00006984
<141>2018-09-13
<160>4
<170>SIPOSequenceListing 1.0
<210>1
<211>31
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>1
caactcggcc ctggtccaac tcgcgtcatt g 31
<210>2
<211>30
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>2
cgaaagccgg gactgaagta cacagatcag 30
<210>3
<211>45
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>3
tgcgatgatc gactccgtgt tgacccgagt gagcggtacc atcct 45
<210>4
<211>2039
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>4
gttatttcga cacttcgcac tctctctaca atggggaacg ttcaaacctc cgtcaacact 60
tacaatatta ctggggatgg taattcattt acccccacct ctgacatgac atccaccgcc 120
gccccggcca ttgacctcaa acctggggtt ctcaatccta ccggtaagct atggcgaccc 180
gtcggtacct ctgttgctac catcgactca cttgccatcg ttagcgatcg ttttggtcag 240
tattcatttg tcaatgaagg catgcgagag accttttcaa aagcgctctt cgacatcaac 300
atgtggcaac ctttattcca agcgacaaag actggctgcg gaccgattgt actctcctcc 360
ttcacaacca ccacctccgg ttatgttggc gccaccgccg gtgatgccct tgacaaccct 420
gtaacgaatg gcgttttcat cagtactgtg caaatcatga accttcagcg gaccatcgct 480
gcccgcatgc gtgacgtcgc tctctggcag aaacacttag acaccgccat gaccatgcta 540
acacctgaca tttctgccgg tagcgcctcc tgcaactgga agagcttgct cgcttttgcg 600
aaggatatcc tccccctcga caacctgtgc ctcacctacc caaatgagtt ctacaacgtt 660
gccatccacc gctatcccgc actcaagcct ggtaacccag acaccaagct tcccgatgcc 720
caggctcatc cgctgggaga agtagccggt gcgttcaatg ccgccacctc tgaagttggg 780
agtctcgttg gttccagctc caccctctca caggccatct ccaccatggc tggcaaagac 840
ctcgatctaa ttgaagccga cactccgctc cccgtgagcg tatttactcc atctctcgcc 900
cctcgttctt atcgacccgc cttcattaaa cctgaggatg ctaagtggat cgcggaattc 960
aataactcat ccctcatacg taagactctt acctactcgg gtgccaccta caccgttcaa 1020
ctcggccctg gtccaactcg cgtcattgat atgaatgcga tgatcgactc cgtgttgacc 1080
ctggatgtga gcggtaccat cctcccatat gacacaaacc ctgatctgtc tacttcagtc 1140
ccggctttcg tcctcatcca gacctcagta ccaattcaac aagtcactac cgctgctaac 1200
atcacagcca tcaccgtcgt atccgccgct ggcgcttccg ccatcaatct cgctatcaat 1260
gtacgcggcc agccccgctt caacatgctc cacctgcaag ccacctttga gcgcgagaca 1320
atcaccggga tcccgtatat ctatggcttg ggcacattcc tcatcccatc acccacatcc 1380
tcctccaatt tctccaaccc cacgctgatg gacggccttc tcactgtcac ccccgtactg 1440
ctacgtgaga cgacatacaa gggcgaagtc gttgacgcta tcgtaccagc taccgtcatg 1500
gccaaccaaa cgtctgagga ggtcgcctct gccttagcca acgacgcgat cgtgttagtg 1560
tcgaatcatc tcaacaagtt ggccaatgtc gtaggagacg cgattcccgt cgcctcaaga 1620
acggatgatt ccgcgactag cgccatcgtc agtcgactcg ccgtccagca caagctgtca 1680
caggtaggcc aagcctcacc cactcccccc gattatccac ttctgtggcg ccgtgccaag 1740
cgtgccgcgt ctatgttcgt ctccaacccc tccctggcct tgcaggtagg tatccctgtg 1800
ttaactcaat ctggtatgct ttccgcccta acgtctggcg taggcacggc tttacgtact 1860
ggtagcttgg gcaaaggtgt aaccgatgcg tcagaaaaac tacgtgcacg tcagagtttg 1920
acggttgcga agcaagcgtt cttcgaccag atagggagct tgtggcccgg caagtgaggg 1980
gtgggttgac aacccccttc catgcccgcg tgaacggcgg gaagtgtcgt actttcatc 2039
Claims (10)
1. A detection kit for grass carp hemorrhagic disease type I virus (GCRV-I) nucleic acid comprises: the kit comprises a grass carp bleeding disease type I virus forward primer, a reverse primer and a specific fluorescent probe, wherein the nucleotide sequence of the grass carp bleeding disease type I virus forward primer is shown as SEQ ID No.1, the nucleotide sequence of the grass carp bleeding disease type I virus reverse primer is shown as SEQ ID No.2, the nucleotide sequence of the specific fluorescent probe is shown as SEQ ID No.3, a fluorescent reporter group is marked at the 5 'end of the specific fluorescent probe, and a fluorescent quenching group is marked at the 3' end of the specific fluorescent probe.
2. The nucleic acid detection kit according to claim 1, wherein the fluorescence reporter group of the specific fluorescent probe is selected from one of FAM, VIC, JOE, TET, CY3, CY5, ROX, Texas Red or LC RED460, and the fluorescence quenching gene is selected from one of BHQ1, BHQ2, BHQ3, Dabcy1 or Tamra.
3. The nucleic acid detection kit according to claims 1 and 2, further comprising at least one of a primer mixture, a specific fluorescent probe, an ABuffer, a B Buffer, a RAA dry powder reagent, a grass carp hemorrhagic disease type I virus standard, and DEPC treated water.
4. The kit of claim 3, wherein the reverse transcription system comprises RTE reverse transcriptase and RNase inhibitor.
5. The kit according to claim 3, wherein the A Buffer is 20% PEG; b Buffer is 280mM MgAc.
6. The kit of claim 5, wherein the RAA dry powder reagent is comprised of: 1mmol/LdNTP, 90ng/μ L SSB protein, 120ng/μ L recA recombinase protein (SC-recA/BS-recA) or 30ng/μ L Rad51, 30ng/μ L Bsu DNA polymerase, 30ng/mL RTE reverse transcriptase, 100mmol/L Tricine, 20% PEG, 5mmol/L dithiothreitol, 100ng/μ L creatine kinase, and Exo exonuclease.
7. The nucleic acid detection kit according to any one of claims 1 to 5, wherein the standard substance of the grass carp hemorrhagic disease type I virus is a positive plasmid containing a partial sequence of a gene of a conserved region of the grass carp hemorrhagic disease type I virus.
8. The kit according to claim 6, wherein the positive plasmid containing the partial sequence of the conserved region gene of grass carp hemorrhagic disease type I virus has the sequence shown in SEQ ID No. 4.
9. An RAA constant-temperature fluorescence detection method for grass carp bleeding disease type I virus comprises the steps of extracting RNA of a sample to be detected, carrying out real-time fluorescence RAA reaction in the presence of a forward primer, a reverse primer, a specific fluorescence probe, an RAA dry powder reagent, an A Buffer, a B Buffer and DEPC (diethylpyrocarbonate) treated water of the grass carp bleeding disease type I virus by taking the RNA of the sample to be detected as a template, and analyzing the sample to be detected according to a real-time fluorescence RAA amplification curve; the nucleotide sequence of the grass carp hemorrhagic disease type I virus forward primer is shown as SEQ ID No.1, the nucleotide sequence of the grass carp hemorrhagic disease type I virus reverse primer is shown as SEQ ID No.2, the nucleotide sequence of the specific fluorescent probe is shown as SEQ ID No.3, the 5 'end of the specific fluorescent probe is marked with a fluorescent reporter group, and the 3' end of the specific fluorescent probe is marked with a fluorescent quenching group.
10. The method as claimed in claim 9, wherein the RNA extraction of grass carp hemorrhagic disease type I virus nucleic acid is performed by using a traditional Trizol-RNA reagent or an equivalent RNA extraction kit.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811069533.XA CN110894551A (en) | 2018-09-13 | 2018-09-13 | RAA constant-temperature fluorescence detection method and reagent for grass carp hemorrhagic disease type I virus (GCRV-I) |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811069533.XA CN110894551A (en) | 2018-09-13 | 2018-09-13 | RAA constant-temperature fluorescence detection method and reagent for grass carp hemorrhagic disease type I virus (GCRV-I) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110894551A true CN110894551A (en) | 2020-03-20 |
Family
ID=69785665
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811069533.XA Pending CN110894551A (en) | 2018-09-13 | 2018-09-13 | RAA constant-temperature fluorescence detection method and reagent for grass carp hemorrhagic disease type I virus (GCRV-I) |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110894551A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112048575A (en) * | 2020-10-26 | 2020-12-08 | 深圳市莱孚生物科技有限公司 | Primer, probe and detection method for identifying grass carp hemorrhagic fever virus |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103484568A (en) * | 2013-09-18 | 2014-01-01 | 中国水产科学研究院珠江水产研究所 | Method and kit for dual fluorescence quantitative PCR detection of grass carp reovirus types I and II |
| CN107760716A (en) * | 2017-10-27 | 2018-03-06 | 河南师范大学 | The preparation method of GCRV S11 gene eucaryon expression recombinant plasmids and its application as nucleic acid vaccine |
| CN108103240A (en) * | 2017-11-10 | 2018-06-01 | 杭州众测生物科技有限公司 | Prawn infectivity muscle necrosis virus（IMNV）RAA constant temperature fluorescence detection method and reagent |
-
2018
- 2018-09-13 CN CN201811069533.XA patent/CN110894551A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103484568A (en) * | 2013-09-18 | 2014-01-01 | 中国水产科学研究院珠江水产研究所 | Method and kit for dual fluorescence quantitative PCR detection of grass carp reovirus types I and II |
| CN107760716A (en) * | 2017-10-27 | 2018-03-06 | 河南师范大学 | The preparation method of GCRV S11 gene eucaryon expression recombinant plasmids and its application as nucleic acid vaccine |
| CN108103240A (en) * | 2017-11-10 | 2018-06-01 | 杭州众测生物科技有限公司 | Prawn infectivity muscle necrosis virus（IMNV）RAA constant temperature fluorescence detection method and reagent |
Non-Patent Citations (2)
| Title |
|---|
| XIU-YING YAN等: "Phylogenetic analysis of newly isolated grass carp reovirus" * |
| 吕蓓等: "用重组酶介导扩增技术快速扩增核酸" * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112048575A (en) * | 2020-10-26 | 2020-12-08 | 深圳市莱孚生物科技有限公司 | Primer, probe and detection method for identifying grass carp hemorrhagic fever virus |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107988428B (en) | RAA constant temperature fluorescence detection method and reagent for Shrimp Iridovirus (SIV) | |
| CN107988325B (en) | RAA constant temperature fluorescence detection method and reagent for shrimp liver Enterocytozoon (EHP) | |
| CN107828914B (en) | RAA constant temperature fluorescence detection method and reagent for Infectious Hypodermal and Hematopoietic Necrosis Virus (IHHNV) | |
| CN110564895A (en) | RAA constant-temperature fluorescence detection primer probe set, kit and method for feline herpesvirus FHV-1 | |
| CN107988427A (en) | Prawn hepatopancreatic parvovirus（HPV）RAA constant temperature fluorescence detection method and reagent | |
| CN110592268A (en) | RAA constant temperature fluorescence detection method and reagent for lake luo virus (TiLV) | |
| CN110592269A (en) | RAA constant-temperature fluorescence detection method and reagent for grass carp hemorrhagic disease type 2 virus (GCRV-2) | |
| CN107190103B (en) | Multiplex PCR primer group, kit and method for simultaneously detecting three fish viruses | |
| CN109055618A (en) | For detect the specific primer of infectious spleen and kidney necrosis virus to, probe, detection kit | |
| CN110894550A (en) | RAA constant temperature fluorescence detection method and reagent for eel Herpes Virus (HVA) | |
| CN110894546A (en) | RAA constant temperature fluorescence detection method and reagent for fish viral nervous necrosis disease virus (VNNV) | |
| CN108998575B (en) | Establishment of double PCR detection method for chicken parvovirus and chicken newcastle disease virus | |
| US20230250497A1 (en) | One-step nested pcr primers set and kit modified with locked nucleic acid for detecting african swine fever virus | |
| CN108998576B (en) | Specific primer pair, probe and detection kit for detecting spring carp virus | |
| CN110592274A (en) | RAA constant temperature fluorescence detection method and reagent for Large Yellow Croaker Iridovirus (LYCIV) | |
| CN110894532A (en) | RAA constant temperature fluorescence detection method and reagent for bacterial septicemia (FBS) | |
| CN110894551A (en) | RAA constant-temperature fluorescence detection method and reagent for grass carp hemorrhagic disease type I virus (GCRV-I) | |
| CN110894549A (en) | RAA constant temperature fluorescence detection method and reagent for Epidemic Hematopoietic Necrosis Virus (EHNV) | |
| CN108588274A (en) | Prawn steals dead nodavirus（CMNV）RAA constant temperature fluorescence detection method and reagent | |
| CN110592271A (en) | RAA constant temperature fluorescence detection method and reagent for Infectious Hematopoietic Necrosis Virus (IHNV) | |
| CN110592270A (en) | RAA constant-temperature fluorescence detection method and reagent for Koi Herpesvirus (KHV) | |
| CN109182597B (en) | Multiplex fluorescence quantitative PCR kit for simultaneously detecting avian adenovirus group I, II and III and detection method thereof | |
| CN110894548A (en) | RAA constant temperature fluorescence detection method and reagent for infectious pancreatic necrosis disease (IPNV) | |
| CN108220481B (en) | Nucleic acid, kit and method for simultaneously detecting congo fever virus, kubo fever virus 1 and 2 types | |
| CN110592267A (en) | RAA constant-temperature fluorescence detection method and reagent for Spring Viremia of Carp Virus (SVCV) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20200320 |